New unit to focus on development of drug candidates through use of HTG Transcriptome PanelContinue reading
Category Archives: AZBio News
Digital Health Technologies Hold Key to New Parkinson’s Treatments
Global stakeholders come together to collaborate with urgency to address unmet needs for Parkinson’s therapies.Continue reading
Opportunity Alert: Flinn Foundation Translational Research Seed Grants Program
The Flinn Foundation will fund up to 10 research teams focused on advancing new products or services to address a compelling clinical need during the next round of its Translational Research Seed Grants Program.Continue reading
TGen Looks Beyond COVID-19 as it Advances Pathogen Sequencing
Genomic analysis of SARS-CoV-2, aided by seqWell’s technology, increases sequencing output by 10-fold
Lilly and Banner Alzheimer’s Institute collaborate on planned Phase 3 prevention trial of donanemab
Trial will include participants at risk for cognitive and functional decline related to Alzheimer’s disease Continue reading
Launch of UNITE4TB Partnership Marks a New Era in Tuberculosis Treatment Development
The partnership will accelerate the development of new Tuberculosis (TB) drug regimens as part of the Innovative Medicines Initiative (IMI), a public-private European Research & Development ConsortiumContinue reading
Like priming a pump, changes in cells damaged by chronic lung disease can result in severe COVID
Results from a TGen-led international study suggest that SARS-CoV-2 takes advantage of genetic changes among patients with pre-existing lung diseasesContinue reading
FDA clears the CATS®-D Disposable Tonometer Prism.
The FDA has cleared the CATS®-D Disposable Tonometer Prism for sale in the United States, assuring that eye care clinicians have accurate intraocular pressure (IOP) measurement data — a key metric — for the diagnosis and treatment of glaucoma and other serious ocular conditions.
The patented CATS®-D Tonometer Prism is designed to deliver improved IOP measurement accuracy with a sterile, disposable tip replacement for the Goldmann tonometer.
TGen study suggests a variety of factors beyond age influence reaction time
Reaction time helps measure healthy vs. diseased brains, revealing potential connections tied to the risk of Alzheimer’s disease and dementiaContinue reading
C-Path Announces Health Care Leader Appointment to Board
TUCSON, Ariz., July 8, 2021 — Critical Path Institute (C-Path) today announced the appointment of health care industry leader and active civic involvement pioneer Mara G. Aspinall, MBA, to its Board of Directors.Continue reading